Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
New England Journal of Medicine (2021) - Comments
doi: 10.1056/nejmoa2105290  issn: 0028-4793  issn: 1533-4406  pubmed: 34587382 

Ann R. Falsey, Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, William Hahn, Julie Hunt, Mark J. Mulligan, Charlene McEvoy, Edwin DeJesus, Michael Hassman, Susan J. Little, Barbara A. Pahud, Anna Durbin, Paul Pickrell, Eric S. Daar, Larry Bush, Joel Solis